Imper Vera 4
4 · Cytek Biosciences, Inc. · Filed Jan 6, 2022
Insider Transaction Report
Form 4
Imper Vera
Director
Transactions
- Award
Stock Option (Right to Buy)
2021-12-31+28,598→ 28,598 totalExercise: $16.32Exp: 2031-12-31→ Common Stock (28,598 underlying)
Footnotes (1)
- [F1]The shares subject to the option vest as follows: 1/36th of the shares subject to the option shall vest monthly over three years from December 31, 2021.